Allosteric Modulation of Nuclear Receptor Function Open Access
Weikum, Emily Rye (2017)
Abstract
Nuclear receptors are a family of ligand-regulated transcription factors that control specific gene programs across numerous biological processes. The assembly of distinct transcriptional complexes drives regulatory specificity, each complex attuned to a particular gene-, cell- and physiologic-context. These distinct complexes are influenced by allosteric effectors, such as DNA sequence and ligands, which modulate nuclear receptor function. These collective works utilize structural biology and biochemistry to examine these allosteric effectors of nuclear receptor function. We explore the idea that different DNA sequences alter nuclear receptor structure. We show that the glucocorticoid receptor can interact directly with a sequence within inflammatory gene promoters. This finding represents a paradigm shift in our understanding of how the glucocorticoid receptor could repress transcription at these sites. We also show the first reported crystal structure of germ cell nuclear factor bound to its DNA response element. This nuclear receptor is critical in development and understanding the DNA binding properties of this protein can gleam insight into its function. In addition to DNA sequences, we also structurally characterize the glucocorticoid receptor ligand-binding domain in complex with a widely used and potent clinical ligand. As there are only a few GR ligand binding domain structures reported, this work provided structural mechanisms driving this highly stabilizing ligand. Furthermore, this work also reports the first glucocorticoid receptor structure in complex with a peptide from the atypical coregulator, small heterodimer partner. Collectively, this work reviews the idea that these allosteric modifications drive different NR surfaces that are read by coregulator proteins, resulting in alternative transcriptional programs.
Table of Contents
Abbreviations 1-5 Chapter 1: Introduction 7 Nuclear Receptor Superfamily 8
Classifications 9-10 Structural Insight Into Nuclear Receptor Action 11
Overall Architecture 11-13 Nuclear Receptor-Ligand Interactions 13-14 Nuclear Receptor-DNA Interactions 14 Nuclear Receptors can form monomers, dimers, or heterodimers 14-15 Nuclear Receptor-Coregulator Interactions 15-16
Nuclear Receptor Signaling 16 Nuclear Receptor Mechanism of Action 16-17 Transactivation and Transrepression 17-18
Nuclear Receptors as Critical Pharmaceutical Targets 18-19 Tables and Figures
Table 1.1: Nuclear Receptor Superfamily 20-22 Figure 1.1: Modular Domain Structure of Nuclear Receptors 23 Figure 1.2: Nuclear Receptor DNA Binding Domains 24 Figure 1.3: Nuclear Receptor Ligand Binding Domains 25
8
Figure Figure Figure Figure Figure
Figure
References
1.4: Nuclear Receptor-Ligand Interactions
1.5: Genomic Response Elements
1.6: Nuclear Receptor Dimerization Interfaces 1.7: Nuclear
Receptor-Coregulator Interactions 1.8: Schematic of Nuclear
Receptor
Signaling Mechanisms
1.9: Nuclear Receptors both Activate and Repress Transcription
26-27 28-29 30-31 32-33
34-35
36-37 38-53
54
56 57-59 59-64 60-62 63-64 65-67 67-76 68-70 70-71 72-75
Chapter 2: Glucocorticoid Receptor Control of Transcription: Precision and Plasticity via Allostery
Author Summary Abstract
Introduction GR-Genome Interactions
Direct and indirect sequence-specific binding in vitro
Context-specific genomic occupancy in vivo
GRE Context and Regulatory Logic Allosteric Effectors of GR
DNA binding sequences LBD-binding ligands Post-translational modifications
9
Composite GRE-bound non-GR TRFs
Coregulators as GR signaling readers
Basis of GR-coregulator interactions Functional classes of GR coregulators Structural and enzymatic complexes Chromatin remodeling complexes Methyltransferases
Histone acetyltransferases (HATs)
Histone deacetylases (HDACs)
Precision and Plasticity Via Allostery Conclusions and
Perspectives Acknowledgements
Figures and Tables
Figure 2.1: Glucocorticoid receptor signaling and DNA binding
Figure 2.2: Modes of site-specific glucocorticoid receptor-genome interactions
Figure 2.3: Context-specific glucocorticoid receptor occupancy and gene regulation
Figure 2.4: Glucocorticoid receptor-ligand interactions
Figure 2.5: Sites of glucocorticoid receptor post-translational modifications
75-76 76-81 77 77-78 78-79 80
80 80-81 81 81-82 83-84 85
86-87 88-89
90-91 92-93
94
10
Figure 2.6: A model of transcriptional regulation - precision and plasticity of TRF function achieved via allostery
Table 2.1: Five functional classes of regulators reported to interact with GR
Supplemental Table 2.1: Methods to probe glucocorticoid receptor-DNA interactions
References
95-96 97
98-102
103-136
Chapter 3: The Glucocorticoid Receptor Binds Directly to a GR Half-Site Sequence Embedded Within AP-1 Recognition Motifs
Author Summary Abstract Introduction Results
GR is recruited to AP-1 target genes in a DNA-binding dependent manner
GR Ser425Gly mutation cannot be used to distinguish DNA-binding-dependent from independent mechanisms
GR represses AP-1 target genes in the absence of tethering
factors GR binds directly to TREs
GR recognizes TREs in a sequence specific manner
GR and AP-1 likely compete for the same binding site
Discussion
Materials and Methods
137
139 140-142
143-144
144-145 145-146 146-147 148-149 149-150 151-154 155-161
11
Reporter Gene Assays 155
ChIP-PCR 156-157
Protein Expression and Purification 158
Nucleic Acid Binding Assays 158-159
NMR Analysis 159-160
Structure Determination of GR-TRE Complexes 160
Generation of Lys442Ala/Arg447Ala "DNA Dead" and GR Ala458Thr/Ile634Ala (GR mon) mutants 161
TR-FRET Competition Assays 161 Acknowledgements 162 Figures and Tables 163-173
Figure Figure
Figure Figure
Figure
References 174-183
3.1: WT GR, but not GR Ser425Gly, is recruited to
TREs
in the absence of tethering factors 163-164
3.2: WT GR, but not Lys442Ala/Arg447Ala, is able to
transrepress inflammatory genes 165-166
3.3: GR binds a variety of TRE sequences 167 3.4: Monomeric GR is preferred to repress inflammatory
genes 168-169 3.5: Crystal structures of GR DBD bound to the IL11 TRE,
VCAM1 TRE, and a GBS 170-171
3.6: GR and AP-1 compete for the same DNA binding site 172 Table 3.1: Data collection and refinement statistics 173
Figure
12
Chapter 4: Structural analysis of the glucocorticoid receptor ligand-binding domain in complex with triamcinolone acetonide and a fragment of the atypical coregulator, SHP
Author Summary 184 Abstract 186 Introduction 187-189 Materials and Methods 190-194
Protein expression and purification 190 Protein crystallization, data collection, and structure determination 190-191
Ligand binding and competition assays Differential
scanning fluorimetry (DSF) ProSMART analysis
Molecular Dynamics Simulations
Results
191-192 192 192-193 193-194 195-200 195-196
GR LBD over Dex, similar to MF 196-197 TA increases intramolecular contacts within the LBD to drive affinity and
Structural analysis of AncGR2-Triamcinolone/SHP
complex
The C-17 acetonide moiety on TA increases the affinity and
stability for
stability
Recognition of the SHP NR Box1 LXXLL Motif
198-199 199-200 201-203 204
Discussion Acknowledgements
13
Figures and Tables
205-214 205
206 207-208 209-210 211-212
213
214 215-224
Figure Figure
Figure Figure Figure Figure
4.1: Structure of the AncGR2-TA-SHP NR Box 1 Complex
4.2: MD simulations support LBP-Hydrogen bonding interactions
4.3: TA readily competes Dex out of the binding pocket and highly stabilizes the LBD
4.4: Comparison of glucocorticoid ligands bound to AncGR2 LBD
4.5: Structural comparison of different GR-ligand complexes
4.6: AncGR2-TA complex is bound by atypical coregulator, SHP
Table 4.1: Data collection and refinement statistics
References
Chapter 5: Structural Investigation into Oct4 Regulation by Orphan Nuclear Receptors, Germ Cell Nuclear Factor (GCNF) and Liver Receptor Homolog-1 (LRH-1)
Author Summary 225 Abstract 227 Introduction 228-231 Results 232-236
GCNF and LRH-1 directly bind the mOct4 DR0 232 Structural analysis of GCNF and LRH-1 - Oct4 complexes 232-233
14
LRH-1 and GCNF differentially recognize the DR0 of the Oct4 proximal promoter
Discussion Methods
234-236 237-240 241-244
Protein expression and purification
Generation of GCNF DBD Gly149Arg/Pro151Arg and LRH-1 DBD
Arg160Gly/Arg162Pro 242 Sequence alignments and analysis 242 Nucleic acid binding analysis 243 Crystallization, data collection, and structure determination 243-244 Accession Numbers 244
Acknowledgements 245
Figures
Figure
246-254
5.1: Schematic representation of differential regulation of Oct4 by LRH-1 and GCNF 246
Figure
Figure
Figure
Figure
Figure
Table 5.1: Data collection and refinement statistics
254
5.2: GCNF and LRH-1 bind directly to the Oct4 DR0
247
5.3: Structural analysis of GCNF-mOct4
complex 248-249 5.4: Interactions between
GCNF molecules 250
5.5: Structural
analysis of LRH-1-mOct4 complex
251
5.6: GCNF and LRH-1 comparison
252-253
References 255-260
241-242
15
Chapter 6: Discussion
Conclusions
DNA as an allosteric modulator Ligands as allosteric modulators NRs as scaffolds
Remaining Questions and Future Directions
Can the Oligomeric state of GR distinguish transactivation from transrepression?
Are GR selective gene modulators possible?
What techniques are on the horizon for expanding our understanding of NRs?
Concluding Remarks Figures
Figure 6.1: G-C and A-T base pairs
Figure 6.2: Generation of GR DIMER
References
262-270 262-268 268-269 269-270 270-271
270-272 272
274
274 275-277 275 276-277 278-283
About this Dissertation
School | |
---|---|
Department | |
Subfield / Discipline | |
Degree | |
Submission | |
Language |
|
Research Field | |
Keyword | |
Committee Chair / Thesis Advisor | |
Committee Members |
Primary PDF
Thumbnail | Title | Date Uploaded | Actions |
---|---|---|---|
|
Allosteric Modulation of Nuclear Receptor Function () | 2018-08-28 15:31:39 -0400 |
|
Supplemental Files
Thumbnail | Title | Date Uploaded | Actions |
---|